387. BiomEdit’s Aaron Schacht on innovation pipeline, approaching scientific discovery + developing “and” solutions in animal health

From innovation pipeline movement to Series B funding, leadership changes and so much more, BiomEdit is on the move. This week, CEO Aaron Schacht joins Agbioscience to talk scientific discovery, artificial intelligence, creating “and” solutions and how he approaches adding to his team in a meaningful way. Highlights include:  An overview of BiomEdit’s innovation pipeline and what has Aaron most excited right now Optavant – BE-101 – and its movement through the USDA regulatory process, what the technology is designed to do and its benefit to the poultry industry Creating solutions that establish certainty for producers – having the economics make sense to where they can realize the full genetic potential of the animal Finding the right messages to connect consumers to straightforward understanding of how their food is produced and why these innovations are so important for them How the BiomEdit team approaches scientific discovery  The company’s latest Series B fundriase — $18.4 M – and what it will enable the company to do New leadership additions and how they add not only competencies, but culture to the BiomEdit team Aaron’s vision for the continued opportunity to marry the AI-driven predictive analysis with scientific discovery to drive this work forward – and some incredible updates for their team in this space What’s ahead for BiomEdit